NKTR-181

The opioid drug that addicts don't like could be approved next spring
The opioid drug that addicts don't like could be approved next spring
Bizjournals.com
Nektar Therapeutics
NKTR-181
opioids
opiod crisis
Flag link:
[video]What’s Next for Nektar Therapeutics?
[video]What’s Next for Nektar Therapeutics?
Motley Fool
Nektar
NKTR-181
Flag link:
Nektar's Pain Drug Disappoints
Nektar's Pain Drug Disappoints
Yahoo/Zacks
pain management
NKTR-181
Nektar
Flag link:
Nektar Plummets After Pain Drug Misses Goals of Mid-Stage Study
Nektar Plummets After Pain Drug Misses Goals of Mid-Stage Study
Bloomberg
Nektar
NKTR-181
chronic pain
Flag link:
Rough market day for Nektar, while Pharmacyclics and Regeneron soar
Rough market day for Nektar, while Pharmacyclics and Regeneron soar
Marketwatch
Nektar
Pharmacyclics
Regeneron
osteoarthritis
NKTR-181
ibrutinib
Flag link:
This Week in Biotech
This Week in Biotech
Motley Fool
Nektar
NKTR-181
pain management
Novartis
serelaxin
Idenix
IDX20963
hepatitis C
ViroPharma
JNJ
Aragon
ARN-509
prostage cancer
Flag link:
Nektar Therapeutics Gains on Trial of New Painkiller
Nektar Therapeutics Gains on Trial of New Painkiller
Bloomberg
Nektar
NKTR-181
abuse-resistant painkillers
Flag link:
Nektar Therapeutics says FDA gives fast track incentives to chronic pain drug NKTR-181
Nektar Therapeutics says FDA gives fast track incentives to chronic pain drug NKTR-181
Yahoo/AP
fast track
chronic pain
FDA
Nektar
NKTR-181
Flag link:
Nektar starts trial on next-generation opioid
Nektar starts trial on next-generation opioid
Bizjournals.com
opiods
Nektar
painkillers
NKTR-181
Flag link:
Nektar Announces Two Preclinical Data Presentations at Society for Neuroscience 40th Annual Meeting: Neuroscience 2010
Nektar Announces Two Preclinical Data Presentations at Society for Neuroscience 40th Annual Meeting: Neuroscience 2010
Yahoo/PR NewsWire
Nektar
NKTR-181
pain management
abuse-resistant painkillers
opiods
Flag link: